Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy and bone marrow transplant can cause permanent hair loss.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Effective hair loss assessment requires a mix of precise measurement methods.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

The research found that a specific gene mutation causes fewer hair follicles and disrupted hair growth cycles, leading to thin and short hair in people with Hypotrichosis with Juvenile Macular Dystrophy.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

White and yellow dots indicate severe female hair loss in dark skin.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Isotretinoin was not effective in treating facial lichen planopilaris.

The boy with woolly hair nevus had thinner hair and abnormal hair follicles, which improved with treatment but worsened when treatment stopped.

Combination therapy promotes better hair growth and density.